These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1171280)

  • 1. [Modes of cytocidal action of antineoplastic agents and methods of their administration].
    Kimur K; Niitani H; Sakai Y; Chikada C; Shimoyama M
    Nihon Rinsho; 1975 May; 33(5):1862-72. PubMed ID: 1171280
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of solid tumors with N-1-(2'-tetrahydrofuryl)-5-fluorouracil (FT-207) alone and in combination: comparison of intravenous and oral administration].
    Saito T; Wakui A; Yokoyama M; Takahashi H; Takahashi K
    Nihon Gan Chiryo Gakkai Shi; 1974 Nov; 9(4):395-406. PubMed ID: 4476739
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative evaluation of the efficacy of fluorofur (Ftorafur) and 5-fluorouracil (5-ftouracil) in the treatment of breast cancer].
    Karev N; Blokhina N; Voznyi E; Perscin M
    Minerva Med; 1974 Jul; 65(52):2811-4. PubMed ID: 4846402
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of Ftorafur (author's transl)].
    Rieche K; Matthes ML
    Arch Geschwulstforsch; 1975; 45(5):496-501. PubMed ID: 1212068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with furanidyl-fluorouracil in advanced tumours of the breast.
    Cichy A; Jurga L; Klvana M
    Neoplasma; 1974; 21(6):723-32. PubMed ID: 4614094
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of the effects of ftorafur and 5-fluorouracil in breast cancer (author's transl)].
    Karev NI; Blochina NG; Voznyj EK; Persin MP
    Cas Lek Cesk; 1975 Jul; 114(29):903-6. PubMed ID: 1098776
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of treatment of malignant tumors with ftorafur.
    Blokhina NG; Vozny EK; Garin AM
    Cancer; 1972 Aug; 30(2):390-2. PubMed ID: 5051663
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical use of 5-fluorouracil in surgical field].
    Suzuki T; Nishimura G; Imamura K; Sugahara K; Fujii Y
    Gan No Rinsho; 1969 May; 15(5):459-68. PubMed ID: 5387578
    [No Abstract]   [Full Text] [Related]  

  • 9. Experience with ftorafur treatment in breast cancer.
    Karev NI; Blokhina NG; Vozny EK; Pershin MP
    Neoplasma; 1972; 19(4):347-50. PubMed ID: 5054534
    [No Abstract]   [Full Text] [Related]  

  • 10. [A comparative study on the preoperative administration of 5-FU DS and FD-1 against gastric cancer--with special reference to histological findings (author's transl)].
    Okada K; Kitade F; Sekimoto T; Kawashima Y; Yagi A; Yamada S; Sakuramoto K; Kato Y; Osawa N; Okajima K
    Nihon Gan Chiryo Gakkai Shi; 1979 Apr; 14(2):129-37. PubMed ID: 448219
    [No Abstract]   [Full Text] [Related]  

  • 11. [590-S].
    Furue H
    Gan No Rinsho; 1985 May; 31(6 Suppl):739-45. PubMed ID: 4032755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cooperative phase II study of spansule tegafur (SF-SP)].
    Taguchi T
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):319-26. PubMed ID: 6421250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical application of 5-fluorouracil--with special reference to the evaluation of the intravenous administration method].
    Hamaguchi E; Utsunomiya J; Hishigi S; Nakamura T
    Gan No Rinsho; 1968 Sep; 14(9):793-803. PubMed ID: 5750379
    [No Abstract]   [Full Text] [Related]  

  • 14. Capecitabine and oxaliplatin (XELOX) is safe and effective in patients with advanced gastric cancer.
    Quek R; Lim WT; Foo KF; Koo WH; A-Manaf A; Toh HC
    Acta Oncol; 2007; 46(7):1032-4. PubMed ID: 17917832
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacokinetic studies of a new fluorinated pyrimidine, 590-S (PH-FU), in human patients].
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2193-8. PubMed ID: 3717963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phase II study of 590-S (1-phthalidyl-5-fluorouracil) in patients with gastrointestinal cancer. Tokyo Cancer Chemotherapy Cooperative Group].
    Nakatsu T; Takahashi H; Furue H
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3114-8. PubMed ID: 3674897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy of inoperable cancer of the stomach].
    Raevskiĭ IG
    Sov Med; 1974 Oct; (10):30-5. PubMed ID: 4428239
    [No Abstract]   [Full Text] [Related]  

  • 18. [5-Fluorouracil concentration in various tissues from cancer patients after oral administration of 5-fluorouracil].
    Nakamura T; Hashimoto I; Sawada Y; Mikami J; Yoshimoto M; Nishidai H; Nakanishi Y; Kashi Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):1037-48. PubMed ID: 6721512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of factors affecting clinical cancer chemotherapy].
    Wakui A; Taguchi T
    Gan No Rinsho; 1983 Aug; 29(10):1199-204. PubMed ID: 6415312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Methotrexate and 5-fluorouracil with leucovorin therapy in advanced gastric cancer: the enhancement of 5-fluorouracil antitumor activity by leucovorin].
    Sugiura I; Ogasawara T; Kinoshita T; Ono Y; Onizuka T; Nagata K; Kamiya O; Ohara K; Hoshino A
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1938-40. PubMed ID: 3496053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.